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Between 1952 and 1958, forty thousand troops witnessed or assisted in the detonation of 
nuclear weapons in and around Australia and Christmas Island. Of these forty thousand troops 
there were 550 sailors from New Zealand; the remainder were mainly from Australia or 
Britain, together with a Fijian contingent. Since the end of this test series, the participants 
have maintained that they were exposed to radiation that has affected their health. The New 
Zealand test veterans say that their lifespan has been reduced by at least 10 years and there 
have been an unusually high number of genetic disorders among them and their children. The 
possible genetic effects of this radiation exposure have never been fully investigated. 
One of the most popular techniques for detecting DNA damage is the single-cell gel 
electrophoresis assay (SCGE), also known as the COMET assay. The COMET assay was 
used throughout this study to determine if veterans of the Operation Grapple tests have long-
term genetic effects as a result of their participation. The COMET assay measured three 
factors to determine the overall genetic damage in these veterans: the tail length; the tail 
moment; and the Olive tail moment. Only the tail length had a significant amount of 
difference after a comparison with a control group was conducted (P = 0.046). However, the 
mean genetic damage in these veterans was lower than that of the control group. It is unclear 
if this result is due to an anomaly in the data, or due to some other complex factor. An 
epidemiological analysis revealed a possible link between the mortality of these veterans and 
the number of weapons detonated. 
The collection of these one hundred samples, not including re-collections, from several areas 
of New Zealand became a logistical nightmare. To minimise this problem a pilot study was 
also incorporated into this research to determine if blood samples could be cryopreserved for 
extended periods of time without an accumulation of genetic damage due to the freezing 
process. The COMET assay was also used to determine this damage. The cryopreservation of 
these samples induced extensive genetic damage. Only 7 from the total of 60 frozen samples 
were retrieved with a level of damage that was not significantly different from the original, 
unfrozen sample (P = > 0.050). It appears that the routine use of cryopreserved blood samples 
for cytogenetic testing is not possible at this time and further study is required. 
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a - Alpha 
~-Beta 
BrdU - 5-bromo-2-deoxy-uridine 
Bq - Becquerel 
C - Control group 
Ca - Calcium 
CA - Chromosome Aberration 
CASP - COMET Assay Software Project 
CDC - Centre for Disease Control 
Ci - Curie 
Cm - Centimetres 
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°Co - Cobolt-60 
137Cs - Cesium-137 
CT - Comet Threshold 
DAPI - 4', 6-Diamidino-2-phenylindole 
DMSO - Dimethylsulfoxide 
DNA - Deoxyribose Nucleic Acid 
DPS - Disintegrations Per Second 
DSB - Double-Strand Breakages 
E - Experimental (nuclear test veteran) group 
EDT A - Ethylenediamine Tetraacetic Acid 
EMF - Electromagnetic Field 
EPA - U.S Environmental Protection Agency 
Et al. - Latin, and others 
FCS - Foetal Calf Serum 
FISH - Fluorescence In Situ Hybridisation 
y- Gamma 
G- Grams 
GHz - Gigahertz 
Gy- Gray 
H+ - Proton 
IV 
2H - Deuterium 
3H - Tritium 
H20 - Water 
H20 2 - Hydrogen Peroxide 
HCT - Head Centre Threshold 
HT - Head Threshold 
131 I - Iodine-131 
IDDM - Insulin Dependent Diabetes Mellitus 
192Ir - lridium-192 
KT - Kilotons 
L - Litres 
LET - Low Linear Energy Transfer 
Leuk - Leukocyte 
LMAgarose - Low-Melting-point Agarose 
MCi - Microcurie 
µL - Microlitres 
µm - Micrometers 
µM - Molar concentration in micromoles/litre 
M - Molar concentration in moles/litre 
MA - Milliamperes 
Mb - Megabytes 
Mei - Millicurie 
Mg - Milligrams 
Ml - Millilitres 
Mm - Millimetres 
MN assay- Micronucleus assay 
MqH20 - Milli-Q water 
Ms - Milliseconds 
MSv - Millisieverts 
MT - Megatons 
NaCl - Sodium Chloride 
NaOH - Sodium Hydroxide 
Neutr - Neutrophil 
NIDDM - Non-insulin Dependent Diabetes Mellitus 
v 
Nm - Nanometres 
NMAgarose - Normal Melting-point Agarose 
Nor No. - Number 
NTV - Nuclear Test Veterans 
NZNTV - New Zealand Nuclear Test Veterans 
NZNTVA - New Zealand Nuclear Test Veterans Association 
OTM - Olive Tail Moment 
P - HMNZS Pukaki 
PBMC - Peripheral Blood Mononucleate Cells 
PBS - Phosphate Buffered Saline 
PHA - Phytohaemagglutinin 
R - HMNZS Rotoiti 
R.N.Z.N - Royal New Zealand Navy 
ROS - Reactive Oxygen Species 
RPMI - Roswell Park Memorial Institute 
SCE - Sister Chromatid Exchange 
SCGE - Single Cell Gel Electrophoresis 
SD - Standard Deviation 
SE - Standard Error 
SSB - Single-Strand Breakage 
Ssp. - Sub-species 
85Sr - Strontium-85 
89Sr - Strontium-89 
90Sr - Strontium-90 
Std. Dev - Standard Deviation 
TL - Tail Length 
TM - Tail Moment 
235U - Uranium-235 
V/v - Volume per volume 
WU - U excitation (wide band) filter 
x g - Gravities 
90Y - Yttrium-90 
90Z - Zirconium-90 
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